synovial sarcoma also known malignant rare form cancer occurs primarily extremities arms legs often proximity joint capsules tendon type softtissue sarcoma name synovial sarcoma coined early century researchers thought microscopic similarity tumors synovium propensity arise adjacent joints indicated synovial origin however actual cells tumor develops unknown necessarily primary synovial sarcomas common soft tissue near large joints arm leg documented human tissues organs including brain prostate heart synovial sarcoma occurs per people occur commonly third decade life males affected often females ratio around synovial sarcoma usually presents otherwise asymptomatic swelling mass although general symptoms related malignancies reported diagnosis synovial sarcoma typically made based histology confirmed presence chromosomal two cell types seen microscopically synovial sarcoma one fibrous type known spindle sarcomatous cell relatively small uniform found sheets epithelial appearance classical synovial sarcoma biphasic appearance types present synovial sarcoma also appear poorly differentiated monophasic fibrous consisting sheets spindle cells state extremely rarely monophasic epithelial form causes difficulty differential diagnosis depending site similarity biphenotypic sinonasal sarcoma although genetic findings distinctive like soft tissue sarcomas universal grading system reporting histopathology europe trojani french system gaining nci grading system common united states trojani system scores sample depending tumour differentiation mitotic index tumour necrosis converts grade representing less aggressive nci system also threegrade one takes number factors account immunohistochemistry ihc specific antibody ssxct antibody highly sensitive specific synovial sarcoma used together may obviate need molecular testing cytokeratin typically expressed least focally may positive lack specificity perhaps cases synovial sarcoma associated reciprocal translocation debate whether molecular observation definitive synovial diagnosis synovial sarcoma typically made based histology confirmed presence translocation event gene chromosome one ssx genes chromosome x causes presence fusion gene resulting fusion protein brings together transcriptional activating domain transcriptional repressor domains ssx also incorporates swisnf chromatin remodeling complex well known tumor thought underlie synovial sarcoma pathogenesis dysregulation gene association fusion type tumour morphology fiveyear treatment usually multimodal involving surgery chemotherapy httpsenwikipediaorgwikisynovialsarcoma